TORONTO - Ontario Premier Kathleen Wynne said Wednesday her government will try to find out why watered down chemotherapy drugs were given to more than 1,100 cancer patients, some for as long as a year.

"It's a very worrisome situation, obviously most worrisome for the patients and their families involved, and we will work to find out how this happened," said Wynne.

"I don't know exactly how this happened, but we obviously need to find out how it happened."

Five hospitals — four in Ontario and one in New Brunswick — were contacting patients who received the too-low chemo doses to tell them to immediately get in touch with their oncologist to discuss treatment plans.

There was too much saline added to the bags containing the chemotherapy medications, in effect watering down the drugs by up to 20 per cent.

The hospitals are conducting their own investigations, as is Cancer Care Ontario, and the Ontario College of Pharmacists was on scene at Marchese Hospital Solutions, which prepared the drugs for the hospitals, said Health Minister Deb Matthews.

"I think it's really important to let those people doing the investigations to do their work," said Matthews.

"We all want the highest quality of care, and that includes the appropriate mixing and labelling of drugs."

Questions were raised about the impact the lower than intended doses of the chemotherapy drugs might have had on the treatment for the cancer patients and whether or not they could have lived longer with proper doses.

"What is the implication of that dilution? Does it mean it would affect the outcomes of people's treatment, their longevity," asked Ontario NDP Leader Andrea Horwath.

The provincial Health Ministry and Cancer Care Ontario have a lot of questions to answer, added Horwath.

"I think this rocks people's trust in the health-care system and in the distribution of drugs in Ontario, and that's worrisome," she said.

However, Matthews said the experts assured her the health risks from the watered down cancer drugs were minimal.

"Oncologists tell me the likelihood of this having a serious impact on the health of patients is slight," she said.

Dr. Eshwar Kumar, the CEO of the New Brunswick Cancer Network, said he doubts the diluted drug would have much impact on patients.

"My gut instinct as an oncologist and speaking very generally, it is probably of very minimal impact, but every patient would have to be evaluated individually," Kumar said. "I don't see a situation where a patient would be called back to be given more chemotherapy."

Kumar said the hospital stopped using the drug supply as soon as it learned of the problem last Thursday, and is now mixing the drug themselves.

Oncologists sometimes adjust a patient's dose by up to 20 per cent for a number of reasons such as weight changes and side effects, said Dr. Wylam Faught, who heads the cancer program at The Ottawa Hospital.

"We would anticipate the same chance for a cure or long-term cancer control as we would if we hadn't adjusted the dose," he said in a phone interview.

In this case, he said it's likely "the worry and anxiety is more than the actual negative effect of the cancer treatment."

The chief of oncology at Windsor Regional Hospital said it's important doctors not dismiss their patients' concerns, even if the risk is low.

"I think we just have to be sensitive," Dr. Ken Schneider said.

Marchese Hospital Solutions said it was "deeply concerned" by the questions raised about the quality of its work and is addressing those issues.

"Our preliminary investigation of this issue leads us to be confident that we have met the quality specifications of the contract," the company said on its website.

A total of 990 patients treated or being treated at London Health Sciences Centre, Windsor Regional Hospital, Lakeridge Health in Oshawa and Peterborough Regional Health Centre are affected.

Windsor Regional said 100 of its 290 cancer patients affected had already been contacted by midday Wednesday and given an appointment with their oncologist.

The Ontario patients received lower than intended doses of the drugs cyclophosphamide and gemcitabine, while the Saint John Regional Hospital in New Brunswick said 186 patients received watered down doses of cyclophosphamide.

The drugs were being used as far back as February of last year.

Cancer Care Ontario said all four Ontario hospitals immediately removed the medications received from the drug manufacturer when the problem was discovered late last month, and informed Marchese of the error.

Each hospital has secured new supplies of the medications and Cancer Care Ontario said patients' treatment cycles will not be interrupted.

"It's important to note that chemotherapy preparation and delivery is a complex process and as a result of this complexity, there are sources for potential error," Dr. Carol Sawka, Cancer Care Ontario's vice-president, said in a statement.

The underdosing affected 665 patients at London Health Sciences Centre, 290 patients at Windsor Regional Hospital, 34 at Lakeridge Health, and one patient at Peterborough Regional Health Centre.

Also on HuffPost:

Loading Slideshow...
  • There Are 4 Major Classes Of Breast Cancer

    Results of a massive gene analysis, published last month in the journal <em>Nature</em>, shows that there are <a href="">four major classes</a> of breast cancer, the Associated Press reported. "With this study, we're one giant step closer to understanding the genetic origins of the <a href="">four major subtypes of breast cancer</a>," study researcher Matthew Ellis, M.B., B.Chir., Ph.D., of the Washington University School of Medicine and the Siteman Cancer Center, said in a statement. "Now, we can investigate which drugs work best for patients based on the genetic profiles of their tumors," he added in the statement. "For basal-like breast tumors, it's clear they are genetically more similar to ovarian tumors than to other breast cancers. Whether they can be treated the same way is an intriguing possibility that needs to be explored."

  • Men With Breast Cancer Fare Worse

    Men are less likely to get breast cancer than women -- but when they do, it's <a href="">often deadlier</a>, according to a study presented earlier this year at the American Society of Breast Surgeons meeting. The Associated Press reported that <a href="">men diagnosed with breast cancer</a> live, on average, two fewer years than women who are diagnosed with breast cancer, and are also more likely to have the breast cancer spread, have larger tumors when the cancer is discovered, and be diagnosed later.

  • Cadmium Could Raise Breast Cancer Risk

    Cadmium -- a toxic metal that can be present in foods like shellfish, root vegetables, offal and cereals -- may <a href="">raise risk of breast cancer</a>, according to a March 2012 study in the journal <em>Cancer Research</em>. The research included 56,000 women. Researchers were able to analyze about how much cadmium each woman was consuming based on the cadmium-rich foods in her diet. They found that those who <a href="">consumed the most cadmium</a> had a 21 percent higher breast cancer risk, compared with those who consumed the least cadmium, HuffPost's Catherine Pearson reported.

  • Sleep May Affect Breast Cancer Risk

    Getting six or fewer hours of sleep <a href="">may raise the risk of recurrent breast cancer</a> among post-menopausal breast cancer patients, according to a study in the journal <em>Breast Cancer Research and Treatment</em>. However, this same link was not observed for pre-menopausal breast cancer patients. The findings suggest "that <a href="">lack of sufficient sleep</a> may cause more aggressive tumors, but more research will need to be done to verify this finding and understand the causes of this association," study researcher Cheryl Thompson, Ph.D. said in the statement.

  • A Smallpox Virus Could Be A Promising Treatment

    A <a href="">smallpox virus</a> seems to be promising against a hard-to-treat form of breast cancer, called triple-negative breast cancer, according to a study in mice presented at the 2012 Annual Clinical Congress of the American College of Surgeons. "Based upon pathology, we could see that at least 60 percent of the <a href="">tumors were completely regressed</a> and the other 40 percent had very little areas of tumor cells present with a lot of necrosis, which is a sign that the tumor was responding to therapy," study researcher Dr. Sepideh Gholami, M.D., of Stanford University Medical Center, said in a statement. ABC News pointed out that this <a href="">kind of breast cancer is notoriously hard to treat</a> because it doesn't respond to other hormonal or immune treatments.

  • Shift Work May Influence Breast Cancer Risk

    Working the night shift is linked to an increased risk of breast cancer, according to two different studies that came out this year. One of them, published in the journal <em>Occupational and Environmental Medicine</em>, showed that <a href="">breast cancer risk went up </a>among women who worked the night shift more than twice a week, with the risk being the highest among those who said that they are "morning people" instead of "night people." <em>The Toronto Sun</em> reported that the results of this study confirm the findings of the International Agency for Research on Cancer, which has a list of items and <a href="">habits that may cause cancer</a>. The IARC considers shift work "possibly carcinogenic." The other study, published in the <em>International Journal of Cancer</em>, showed that breast cancer risk is 30 percent higher for <a href="">women who work the night shift</a>, with the risk being especially clear among those working night-time jobs for four years, or those who worked the night shift for three or fewer nights a week.

  • Breast Size May Be Linked With Breast Cancer Risk

    The genes that help determine a <a href="">woman's breast size</a> may also be linked with her breast cancer risk, according to a study published earlier this year in the journal <em>BMC Medical Genetics</em>. Researchers examined the genetic data of 16,000 women to find that seven DNA variations, called single nucleotide polymorphisms (SNPs), seem to be <a href="">linked with breast size</a> -- and three of those SNPs are known to be associated with a person's risk of breast cancer, HuffPost's Catherine Pearson reported.

  • Exercise Could Help Lower Breast Cancer Risk

    Just a little bit of exercise may help to <a href="">reduce your risk of breast cancer</a>, though the more you move, the better, according to a study in the journal <em>CANCER</em>. Researchers at the University of North Carolina in Chapel Hill found that postmenopausal or reproductive-age women in their study who exercised the most -- from 10 to 19 hours each week -- had a 30 percent <a href="">lower risk of breast cancer</a>, though exercising less than that was still linked with some protective benefits. "The observation of a reduced risk of breast cancer for women who <a href="">engaged in exercise after menopause</a> is particularly encouraging given the late age of onset for breast cancer," study researcher Lauren McCullough said in a statement.

  • Type 2 Diabetes May Raise Breast Cancer Risk (For Some Women)

    For post-menopausal women, <a href="">having Type 2 diabetes</a> may raise the risk of breast cancer, according to a review conducted by the International Prevention Research Institute. "On the one hand, it's thought that being overweight, often <a href="">associated with Type 2 diabetes</a>, and the effect this has on hormone activity may be partly responsible for the processes that lead to cancer growth," study researcher Peter Boyle, the president of the International Prevention Research Institute, told <em>The Telegraph</em>. "But it's also impossible to rule out that some factors related to diabetes may be involved in the process."

  • Being Overweight Tied To Worst Breast Cancer Outcomes

    Being overweight could lead to worse outcomes from breast cancer, according to a study published August in the journal <em>Cancer</em>. Specifically, the study showed that overweight women who have been treated for breast cancer have a <a href="">higher risk of recurrence and death</a>, NBC News reported. "Obesity seemed to carry a <a href="">higher risk of breast cancer</a> recurrence and death -- even in women who were healthy at the time that they were diagnosed, and despite the fact that they received the best available chemotherapy and hormone therapy," study researcher Dr. Joseph Sparano, associate chairman of medical oncology at the Montefiore Einstein Center for Cancer Care, told NBC News.

  • Breast Cancer Stages and What They Mean

    Marisa Weiss, MD, of breast, explains the different breast cancer stages and what they mean.